This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (38) Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Stirling, D. P. Articles by Tetzlaff, W. Search for Related Content PubMed PubMed Citation Articles by Stirling, D. P. Articles by Tetzlaff, W. Social Bookmarking                   What's this?

Minocycline as a Neuroprotective Agent

ICORD (International Collaboration On Repair Discoveries), University of British Columbia, Vancouver, BC, Canada

Kaveh M. Koochesfahani

ICORD (International Collaboration On Repair Discoveries), University of British Columbia, Vancouver, BC, Canada

John D. Steeves

ICORD (International Collaboration On Repair Discoveries), University of British Columbia, Vancouver, BC, Canada

Wolfram Tetzlaff

ICORD (International Collaboration On Repair Discoveries), University of British Columbia, Vancouver, BC, Canada, tetzlaff{at}icord.org

Several studies have shown that minocycline, a semisynthetic, second-generation tetracycline derivative, is neuroprotective in animal models of central nervous system trauma and several neurodegenerative diseases. Common to all these reports are the beneficial effects of minocycline in reducing neural inflammation and preventing cell death. Here, the authors review the proposed mechanisms of action of minocycline and suggest that minocycline may inhibit several aspects of the inflammatory response and prevent cell death through the inhibition of the p38 mitogen-activated protein kinase pathway, an important regulator of immune cell function and cell death.

Key Words: Minocycline • Inflammation • Apoptosis • Neuroprotection • P38 MAPK

The Neuroscientist, Vol. 11, No. 4, 308-322 (2005)
DOI: 10.1177/1073858405275175


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				D. Romero-Perez, E. Fricovsky, K. G. Yamasaki, M. Griffin, M. Barraza-Hidalgo, W. Dillmann, and F. Villarreal Cardiac Uptake of Minocycline and Mechanisms for In Vivo Cardioprotection J. Am. Coll. Cardiol., September 23, 2008; 52(13): 1086 - 1094. [Abstract] [Full Text] [PDF]

				L.-p. Yang, X.-a. Zhu, and M. O. M. Tso Role of NF-{kappa}B and MAPKs in Light-Induced Photoreceptor Apoptosis Invest. Ophthalmol. Vis. Sci., October 1, 2007; 48(10): 4766 - 4776. [Abstract] [Full Text] [PDF]

				D. W. Leung, L. A. Lindlief, A. Laabich, G. P. Vissvesvaran, M. Kamat, K. L. Lieu, A. Fawzi, and R. Kubota Minocycline Protects Photoreceptors from Light and Oxidative Stress in Primary Bovine Retinal Cell Culture Invest. Ophthalmol. Vis. Sci., January 1, 2007; 48(1): 412 - 421. [Abstract] [Full Text] [PDF]

				B. C. Hains and S. G. Waxman Activated microglia contribute to the maintenance of chronic pain after spinal cord injury. J. Neurosci., April 19, 2006; 26(16): 4308 - 4317. [Abstract] [Full Text] [PDF]